Pfizer Settles 1st Trial In Chantix Suicide MDL

Law360, New York (October 18, 2012, 5:04 PM EDT) -- Pfizer Inc. settled the first scheduled bellwether trial Wednesday in the multidistrict litigation in Alabama alleging the company should have known its smoking cessation drug Chantix was linked to depression and suicidal behavior, days after it failed to win a stay in the case.

U.S. District Judge Inge Prytz Johnson dismissed the suit, which was set to go to trial Monday, after learning a deal had been reached. Pfizer spokesman Christopher Loder said the terms of the deal were confidential, and an attorney for plaintiff Judy...
To view the full article, register now.